Exelixis, Inc. [EXEL] is following downward trend in the market concluded with the last trading session. The shares of the Healthcare sector company has a current value of $15.51 after EXEL shares went down by -0.26% during the last trading session. One of the reasons why Healthcare stocks may go bearish is decreased momentum in the press.

Exelixis, Inc. [NASDAQ:EXEL]: Analyst Rating and Earnings

Its stock price has been found in the range of 15.02 to 25.31. This is compared to its latest closing price of $15.55.

Pay attention to the next-scheduled financial results for this company to be released, which is slated for Tue 11 Feb (In 91 Days).

Fundamental Analysis of Exelixis, Inc. [EXEL]

Now let’s turn to look at profitability: with a current Operating Margin for Exelixis, Inc. [EXEL] sitting at +50.93 and its Gross Margin at +96.88, this company’s Net Margin is now 64.00%. These measurements indicate that Exelixis, Inc. [EXEL] is generating considerably more profit, after expenses are accounted for, compared to its market peers.

This company’s Return on Total Capital is 54.27, and its Return on Invested Capital has reached 52.60%. Its Return on Equity is 87.77, and its Return on Assets is 66.39. These metrics all suggest that Exelixis, Inc. is doing well at using the money it earns to generate returns.

Turning to investigate this organization’s capital structure, Exelixis, Inc. [EXEL] has generated a Total Debt to Total Equity ratio of 1.16. Similarly, its Total Debt to Total Capital is 0.22, while its Total Debt to Total Assets stands at 1.05.

What about valuation? This company’s Enterprise Value to EBITDA is 12.45 and its Total Debt to

EBITDA Value is 0.00. The Enterprise Value to Sales for this firm is now 6.47, and its Total Debt to Enterprise Value stands at 0.00. Exelixis, Inc. [EXEL] has a Price to Book Ratio of 4.58, a Price to Cash Flow Ratio of 14.80 and P/E Ratio of 7.95. These metrics all suggest that Exelixis, Inc. is more likely to generate a positive ROI.

Shifting the focus to workforce efficiency, Exelixis, Inc. [EXEL] earns $1,747,401 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 6.51 and its Total Asset Turnover is 0.81. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 8.41 and its Current Ratio is 8.50. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.

Exelixis, Inc. [EXEL] has 303.27M shares outstanding, amounting to a total market cap of $4.72B. Its stock price has been found in the range of 15.02 to 25.31. At its current price, it has moved down by -38.72% from its 52-week high, and it has moved up 3.26% from its 52-week low.

This stock’s Beta value is currently 1.76, which indicates that it is 3.87% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 38.29. This RSI score is good, suggesting this stock is neither overbought or oversold.

Conclusion: Is Exelixis, Inc. [EXEL] a Reliable Buy?

Shares of Exelixis, Inc. [EXEL], overall, appear to be a solid investment option, with Wall Street analysts expecting its price to rise considerably in the next 12 months. This company generates high value from the labor resources and other capital it has available, and while it has heavy Long-Term Debt to Equity, the majority of the metrics point to this investment being highly attractive.